Table 3. Clinical outcomes of patients undergoing complex PCI.
| All | BP-BES | DP-EES | p value* | Adjusted HR | 95% CI | p value | ||
|---|---|---|---|---|---|---|---|---|
| Overall population | ||||||||
| No. of patients | 1,145 | 521 | 624 | |||||
| Cardiac death | 24 (2.5) | 10 (2.3) | 14 (2.4) | 0.703 | 0.777 | 0.258–2.337 | 0.653 | |
| TV-MI | 6 (0.6) | 2 (0.4) | 4 (0.7) | 0.694 | 0.665 | 0.121–3.651 | 0.638 | |
| TLR | 21 (2.0) | 5 (1.1) | 16 (2.7) | 0.044 | 0.425 | 0.154–1.177 | 0.100 | |
| ST | 7 (0.7) | 4 (0.8) | 3 (0.5) | 0.708 | 1.836 | 0.409–8.242 | 0.428 | |
| TLF | 44 (4.7) | 15 (3.5) | 29 (5.1) | 0.121 | 0.607 | 0.262–1.404 | 0.244 | |
| Propensity score matched population | ||||||||
| No. of patients | 962 | 481 | 481 | |||||
| Cardiac death | 21 (2.6) | 10 (2.5) | 11 (2.5) | 0.825 | 0.787 | 0.244–2.539 | 0.689 | |
| TV-MI | 4 (0.5) | 2 (0.5) | 2 (0.4) | >0.99 | 1.128 | 0.157–8.093 | 0.905 | |
| TLR | 18 (2.1) | 5 (1.1) | 13 (2.9) | 0.057 | 0.390 | 0.139–1.095 | 0.074 | |
| ST | 5 (0.6) | 4 (0.9) | 1 (0.2) | 0.374 | 4.342 | 0.484–38.927 | 0.189 | |
| TLF | 38 (4.8) | 15 (3.8) | 23 (5.2) | 0.185 | 0.578 | 0.246–1.359 | 0.209 | |
TLF: cardiac death, TV-MI, and TLR.
BP-BES = biodegradable polymer-biolimus-eluting stents; CI = confidence interval; DP-EES = durable polymer-everolimus-eluting stents; HR = hazard ratio; ST = stent thrombosis; TLF = target lesion failure; TLR = target lesion revascularization; TV-MI = target vessel-related myocardial infarction.
*Log-rank p value.